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Abstract
Background: Multilocus sequence typing (MLST) is currently the reference method for genotyping Streptococcus
agalactiae strains, the leading cause of infectious disease in newborns and a major cause of disease in
immunocompromised children and adults. We describe here a genotyping method based on multiple locus
variable number of tandem repeat (VNTR) analysis (MLVA) applied to a population of S. agalactiae strains of various
origins characterized by MLST and serotyping.
Results: We studied a collection of 186 strains isolated from humans and cattle and three reference strains (A909,
NEM316 and 2603 V/R). Among 34 VNTRs, 6 polymorphic VNTRs loci were selected for use in genotyping of the
bacterial population. The MLVA profile consists of a series of allele numbers, corresponding to the number of
repeats at each VNTR locus. 98 MLVA genotypes were obtained compared to 51 sequences types generated by
MLST. The MLVA scheme generated clusters which corresponded well to the main clonal complexes obtained by
MLST. However it provided a higher discriminatory power. The diversity index obtained with MLVA was 0.960
compared to 0.881 with MLST for this population of strains.
Conclusions: The MLVA scheme proposed here is a rapid, cheap and easy genotyping method generating results
suitable for exchange and comparison between different laboratories and for the epidemiologic surveillance of S.
agalactiae and analyses of outbreaks.
Background
Streptococcus agalactiae, one of the group B strepto-
cocci (GBS), is a leading cause of bovine mastitis [1]
and has been implicated in cases of invasive disease in
humans since the 1960s and 1970s [2]. GBS have
emerged as major pathogens in neonates [3] and in
elderly adults, in whom they cause invasive infections,
such as meningitis, soft tissue infections, endocarditis
and osteoarticular infections [4,5]. There is a consider-
able body of evidence to suggest a genetic link between
bovine isolates and the emerging human isolates [6,7].
GBS isolates were initially distinguished on the basis
of differences in capsule polysaccharides, giving rise to
10 different serotypes [8,9]. Serotype III has been identi-
fied as a marker of late-onset neonatal disease isolates
[10], but serotyping does not have sufficient discrimina-
tory power to distinguish between isolates. Molecular
methods have therefore been developed to determine
the genetic relationships between isolates: multilocus
enzyme electrophoresis [11], ribotyping [12], random
amplified polymorphism DNA (RAPD) [13,14] and
pulsed-field gel electrophoresis (PFGE) [15]. These
methods make it possible to compare isolates and to
define particular bacterial genogroups associated with
invasive isolates in neonates. These findings were con-
firmed by multilocus sequence typing, as described by
Jones et al. [16]. Other studies have shown that
sequence type 17 (ST-17) isolates are associated with
invasive behavior [17,18]. Two methods are currently
used to explore the genetic links between isolates: PFGE
* Correspondence: philippe.lanotte@univ-tours.fr
1Université François-Rabelais de Tours, UFR de Médecine, EA 3854 « Bactéries
et risque materno-fœtal », Institut Fédératif de Recherche 136 « Agents
Transmissibles et Infectiologie », Tours, France
Full list of author information is available at the end of the article
Haguenoer et al. BMC Microbiology 2011, 11:171
http://www.biomedcentral.com/1471-2180/11/171
© 2011 Haguenoer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
for epidemiological studies, and MLST for both epide-
miological and phylogenetic studies.
Analyses of fully sequenced bacterial genomes have
revealed the existence of tandemly repeated sequences
varying in size, location and the type of repetition [19].
Tandem repeats (TR) consist of a direct repetition of
between one and more than 200 nucleotides, which may
or may not be perfectly identical, located within or
between genes. Depending on the size of the unit, the
TR may be defined as a microsatellite (up to 9 bp) or a
minisatellite (more than 9 bp) [19]. A fraction of these
repeated sequences display intraspecies polymorphism
and are described as VNTRs (variable number of tan-
dem repeats). The proportion of VNTRs in the genome
varies between bacterial species. Indeed, variation in the
number of repeats at particular loci is used by some
bacteria as a means of rapid genomic and phenotypic
adaptation to the environment [20].
A molecular typing method based on VNTRs variability
has recently been developed and applied to the typing of
several bacterial pathogens [19]. Multiple locus VNTR ana-
lysis, or MLVA, is a PCR-based method that was originally
developed for the typing of Haemophilus influenzae [21],
Mycobacterium tuberculosis [22] and two bacterial species
with potential for use in bioterrorism, Bacillus anthracis
and Yersinia pestis [23,24]. This method has since been
shown to be useful for the genotyping of several other bac-
terial species causing disease in humans, including Strepto-
coccus pneumoniae [25], Legionella pneumophila [26],
Brucella [27,28], Pseudomonas aeruginosa [29] and Staphy-
lococcus aureus [30]. This technique has several advan-
tages. For example, in bacterial species with high levels of
genetic diversity, the study of six to eight markers is suffi-
cient for accurate discrimination between strains [26].
Highly monomorphic species, such as B. anthracis, may be
typed by MLVA, but this requires the use of a larger num-
ber of markers (25 VNTRs for B. anthracis) [31]. The dis-
criminatory power of MLVA may also be increased by
adding extra panels of more polymorphic markers [28] or
by sequencing repeated sequences displaying internal varia-
bility [26]. Conversely, the evaluation of differences in the
number of repeats only, on the basis of MLVA, is a cheap
and rapid method that is not technically demanding. The
work of Radtke et al. showed relevance of MLVA for S.
agalactiae genotyping [32].
Our aim in this study was to develop a MLVA scheme
for the genotyping of a population of S. agalactiae
strains of various origins previously characterized by
MLST.
Methods
Strains
Our collection consisted of 186 epidemiologically unre-
lated S. agalactiae strains, isolated from humans and
cattle between 1966 and 2004 in France. Five of the 152
human strains were isolated from the gastric fluid of
neonates, 71 were isolated from cases of vaginal car-
riage, 59 were isolated from cerebrospinal fluid and 17
were isolated from cultures of blood from adults pre-
senting confirmed endocarditis according to the modi-
fied Duke criteria [33]. The 34 bovine strains were
isolated from cattle presenting clinical signs of mastitis.
We also studied three reference strains: NEM316, A909
and 2603 V/R. Each strain had previously been identi-
fied on the basis of Gram-staining, colony morphology,
beta-hemolysis and Lancefield group antigen determina-
tion (Slidex Strepto Kit®, bioMérieux, Marcy l’Etoile,
France). The capsular serotype was identified with the
Pastorex® rapid latex agglutination test (Bio-Rad, Her-
cules, USA) and by molecular serotyping, as described
by Manning et al. [34]. We were unable to determine
the serotype for 20 strains.
DNA extraction
The bacteria were lysed mechanically with glass beads
and their genomic DNA was extracted with an Invi-
sorb® Spin Cell Mini kit (Invitek, Berlin, Germany).
MLST and assignment to clonal clusters
MLST was carried out as previously described [16].
Briefly, PCR was used to amplify small (≈ 500 bp) frag-
ments from seven housekeeping genes (adhP, pheS, atr,
glnA, sdhA, glcK and tkt) chosen on the basis of their
chromosomal location and sequence diversity. The
seven PCR products were purified and sequenced and
an allele number was assigned to each fragment on the
basis of its sequence. A sequence type (ST), based on
the allelic profile of the seven amplicons, was assigned
to each strain. The sequences of all new alleles and the
composition of the new STs identified are available
from http://pubmlst.org/sagalactiae/. Strains were
grouped into clonal complexes (CCs) with eBURST soft-
ware [35]. An eBURST clonal complex (CC) was defined
as all allelic profiles sharing six identical alleles with at
least one other member of the group. The term “single-
ton ST” refers to a ST that did not cluster into a CC.
Identification of VNTR loci
Tandem repeats were identified in the sequenced gen-
omes of the three reference strains, NEM316, A909 and
2603 V/R, with the Microbial Tandem Repeats Database
http://minisatellites.u-psud.fr[36] and the Tandem
Repeats Finder program [37]. We determined the size of
the repeat sequence and the number of repeat units for
the three reference strains. BLAST analysis was carried
out to determine whether the repeats were located
within or between genes and to identify a hypothetical
function for the open reading frame involved. The TR
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locus name was defined according to the following
nomenclature: common name_size of the repeat sequen-
ce_size of the amplicon for the reference strain_corre-
sponding number of repeats (Table 1). The primers
used for amplification targeted the 5’ and 3’ flanking
regions of selected loci and matched the sequences pre-
sent at these positions in the genomes of strains
NEM316, A909 and 2603 V/R. We initially selected and
evaluated 34 tandem repeats with repeat units of more
than 9 bp in length. Some TRs were not present in all
the strains, some were present in all strains and dis-
played no polymorphism, and others were too large for
amplification in standard conditions. Six TRs were
retained for this study, selected on the basis of their
greater stability and discriminatory power for four of
the six (Table 1).
Multiple locus VNTR analysis (MLVA)
The primers used for the VNTRs amplification are pre-
sented in Table 2. Three loci have already been
described by Radtke et al. in a contemporary study but
were amplified here with other primers [32] (Table 2).
For the SAG7 locus, no amplification was observed with
primers directly flanking the TR for 14% (26/189) of the
strains. A second primer pair targeting larger consensual
flanking regions was designed to confirm the absence of
the locus. PCR was performed in a final volume of 25 μl
containing 10 ng DNA, 1 × PCR Reaction Buffer, 2 mM
MgCl2 (Applied Biosystems), 5% DMSO (dimethyl
sulfoxide), 1 unit of Taq DNA polymerase (Applied Bio-
systems), 200 μM of each dNTP and 0.5 μM of each
flanking primer (Eurogentec, Belgium). Amplification
was performed in a 2720 Thermal Cycler (Applied Bio-
systems) under the following conditions: initial dena-
turation for 5 min at 94°C, followed by 30 cycles of
denaturation for 30 s at 94°C, annealing for 30 s at 50°C
and elongation for 60 s at 72°C plus a final elongation
step for 7 min at 72°C. We separated 10 μl of PCR pro-
duct by electrophoresis in a 2% agarose gel (Eurogentec,
Belgium), which was also loaded with a 100 bp DNA
size ladder (New England BioLabs). Electrophoresis was
performed in 20 cm-long gels, in 1× TBE buffer (89
mM Tris-Borate, 2.5 mM EDTA) containing 1 μg/ml
ethidium bromide run at 10 V/cm. In each run, at least
one lane was loaded with PCR product from one of the
reference strains, NEM316, A909 or 2603 V/R. The gels
were photographed under ultraviolet illumination, with
Vision-Capt® Software (Vilber-Lourmat, Marne la Val-
lée, France). The number of repeats for each VNTR was
deduced from amplicon size, by comparison with the
reference strain, for which the number of repeats was
known. The allele number corresponded to the number
of repeats. For the SAG7 locus, the lack of a VNTR was
revealed by the absence of amplification with the first
primer pair and the amplification of a fragment of the
expected size with the second primer pair, which tar-
geted larger consensual flanking regions. In this case, an
allele number of 0 was given. For the SAG21 locus, a
Table 1 Characteristics of the 6 VNTR loci selected for MLVA scheme to genotype the 186 strains of S. agalactiae
VNTR1 Repeat
size bp2
Putative
function3
Expected number of
repeats4
PCR
product
bp5
Number of
alleles
min-max size of
amplicons (bp)
HGDI6
2603
V/R
A909 NEM316
SAG2_32pb_244pb_3U 32 Non-cds7 3 3 3 244 3 212 - 276 0.474 [0.427
- 0.522]
SAG3_24pb_126pb_2U 24 Protein DnaJ 3 2 3 126 2 126 - 150 0.481 [0.452
- 0.511]
SAG4_60pb_114pb_1U
(SATR1)*
60 Hypothetical
protein
3 1 1 114 6 114 - 414 0.713 [0.691
- 0.735]
SAG7_18pb_285pb_8U
(SATR2)*
18 Hypothetical
protein
6 8 - 285 9 231-573 0.745 [0.701
- 0.789]
SAG21_48pb_783pb_14U
(SATR5)*
48 FbsA - 14 18 783 26 117 - ≈2000 0.893 [0.867
- 0.919]
SAG22_159pb_928pb_5U 159 Hypothetical
protein
2 5 2 928 7 292 - 1246 0.713 [0.666
- 0.761]
1, Tandem repeat locus name defined as follows: common name_size of the repeat sequence_size of the amplicon for the A909 reference strain_corresponding
number of repeats
2, Size of the repeat sequence
3, Putative function of the open reading frame concerned
4, 2603 V/R, A909 and NEM316 number of repeats (-: lack of VNTR)
5, Expected size of PCR product for the A909 reference strain
6, HGDI: Hunter and Gaston’s diversity index, 95% confidence intervals are noted in brackets
7, 69 bp upstream from the ribosomal protein S10 sequence
*, Locus name described by Radtke
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117 bp PCR product was obtained, demonstrating dele-
tion of the inserted sequence and, thus, the absence of a
VNTR. An allele number of 0 was also assigned in this
case. The MLVA genotype of a strain was expressed as
its allelic profile, corresponding to the number of
repeats at each VNTR, listed in the order SAG2, SAG3,
SAG4, SAG7, SAG21, SAG22.
Data analysis
The polymorphism index of individual or combined
VNTR loci was calculated with the Hunter-Gaston
diversity index [38], an application of Simpson’s index
of diversity [39]. Confidence intervals (CI) were calcu-
lated as described by Grundmann et al. [40]. The cate-
gorical coefficient (also called Hamming’s distance) and
unweighted pair group method with arithmetic mean
(UPGMA) clustering approaches were run within Bio-
Numerics. A cutoff value of 50% similarity was applied
to define MLVA clusters. The minimum spanning tree
(MST) was generated with BioNumerics. Each circle
represents an MLVA genotype and its size is propor-
tional to the number of strains. A logarithmic scale was
used when drawing branches. The thicker branches link
the MLVA genotypes differing by only one allele, the
thinner branches link MLVA genotypes differing by
more than one allele.
Results
MLST genotyping
MLST was performed on the 189 S. agalactiae strains,
identifying a total of 51 individual STs. Eburst analysis
clustered the STs into five clonal complexes (CC17,
CC19, CC10, CC23 and CC7), two groups with only two
STs and six singletons (Table 3). Two of the CCs –
CC17 (73 strains) and CC19 (63 strains) – accounted
for 72% (136/189) of the strains. CC23 accounted for
8% (15/189) of the strains. The various serotypes of S.
agalactiae were distributed between multiple CCs and
singleton STs. STs were characterized by a predominant
serotype: serotype V in ST-1, serotype III in ST-17 and
ST-19, serotype Ib in ST-10 and ST-12. ST-23 contained
two serotypes (serotype Ia and III; Table 3). The popula-
tion was therefore representative of S. agalactiae diver-
sity in terms of anatomic origin, serotypes and clonal
complexes (Table 3).
Description of the MLVA scheme
The six VNTRs were amplified from all 189 strains.
MLVA was carried out with individual PCRs and agar-
ose gel electrophoresis of the amplicons, as shown in
Figure 1, for a subset of VNTRs. The repeat unit size of
the six VNTRs was between 18 bp and 159 bp, making
it straightforward to estimate the size of amplicons on
agarose gels. For SAG2, SAG3, SAG4 and SAG7, ampli-
cons were between 114 and 573 bp in size and were
readily resolved by 2% agarose gel electrophoresis (Table
1). For SAG21 (48 bp repeat unit) and SAG22 (159 bp
repeat unit), few amplicons exceeded 1,000 bp and
extensive electrophoretic separation was required for
precise estimations of size. For SAG21, three strains
gave rise to amplicons of more than 1500 bp in size.
This made it difficult to assess the number of repeats
with any degree of precision, and an arbitrary allele
number of > 30 was assigned in these cases. For SAG7,
no amplification with the first primer pair was observed
for 14% of strains. This locus is part of a genomic island
and a second primer pair targeting consensual flanking
regions beyond the borders of this genomic island was
designed to confirm the deletion of the VNTR locus.
The number of alleles was between two for SAG3 and
26 for SAG21. Thus, this MLVA method combined
markers with a low discriminatory power (Hunter and
Gaston’s index of diversity or HGDI < 0.5) with highly
discriminant markers, such as SAG21. With the excep-
tion of SAG2, the VNTRs used in this MLVA method
were located within open reading frames (Table 1).
SAG2 is located upstream from the gene encoding the
ribosomal protein S10; SAG3 is located within dnaJ,
encoding a co-chaperone protein (Hsp40). SAG21 is
located within fbsA, encoding a protein involved in
adhesion. SAG4, SAG7 and SAG22 are located in a
“predicted coding region” of unknown function.
Table 2 Primers used in the MLVA scheme
Forward
primers
Sequence (5’-3’) Coordinates1 Ref
strains2
Reverse
primers
Sequence (5’-3’) Coordinates1
SAG2F TCTTCCAAGTGGTGTCAACG 76270 - 76289 A909 SAG2R CAACGTTTGGAGTTGCTTCA 76494 - 76513
SAG3F CAAAAACGTGCTGCCTATGA 107351 - 107370 A909 SAG3R CATCCCTCCTCCACCAAAA 107458 - 107476
SAG4F GGTCAGTTTTTATTTATCGTAAGC 152991 - 153014 A909 SAG4R AGTCTTGCGAAGGCAGACAC 153085 - 153104
SAG7F TGGTGTTGATAAAGTTGATGTTCC 745963 - 745986 A909 SAG7R GCCATATGAACTGCGGAAAC 746228 - 746247
SAG7bisF ACCTATGCTCCCAGTGGTTC 111555 - 111574 NEM316 SAG7bisR TCACTTAAGCGCACTGCAAC 112036 - 112055
SAG21F TGAAAGAAGTGGATTTTTCCCTA 1062584 - 1062606 A909 SAG21R AAAATAGGTTTTAGAACTTGGAAATCA 1062675 - 1062701
SAG22F TGTAACACTAGCTCCAATTTGTTTT 1745819 - 1745843 A909 SAG22R TCGGTCTTGTCTCAGCAATG 1746727 - 1746746
1, Nucleotide coordinates in the reference strains (A909, NEM316) chosen for primer design
2, Reference strain chosen for primer design
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MLVA genotyping and clustering
The MLVA scheme resolved 98 genotypes among the
189 strains (Table 4). Five MLVA genotypes were repre-
sented by more than five strains: genotype 46 (n = 32),
genotype 47 (n = 13), genotype 33 (n = 11), genotype 57
(n = 7) and genotype 51 (n = 6). Seventy-five MLVA
genotypes were represented by only one strain (Table
4). S. agalactiae strains of different origins were spread
among a number of MLVA genotypes. However 66%
(39/59) of the strains isolated from cerebrospinal fluid
Table 3 Distribution of the 186 S. agalactiae strains studied and the 3 reference strains (NEM316, A909 and 2603 V/R),
as a function of serotype and origin, within MLST clonal complexes
CC
(No. of strains)
ST
(No. of STs)
No. of
strains
(%)1
Serotype
(No. of strains)
Origin of strains (No. of strains)
Vaginal
carriage
Gastric
fluid
Blood Cerebro-spinal
fluid
Bovine Ref
CC17 (73) 17 56 (89%) III (55), ND (1) 15 1 3 37 - -
Other (11) 17 II (5), III (6), ND (6) 2 - - 1 14 -
CC19 (63) 19 27 (43%) II (3), III (23), ND (1) 14 - 1 11 1 -
1 12 V (11), ND (1) 10 - 1 1 - -
Other (13) 24 II (7), III (3), IV (4), V (3), ND
(7)
11 3 3 1 5 1
CC10 (17) 10 9 (53%) Ia (1), Ib (6), II (2) 5 - 2 1 1 -
12 5 Ib (4), II (1) 3 - 2 - - -
Other (2) 3 Ib (3) 1 - 1 1 - -
CC23 (15) 23 10 (67%) Ia (4), III (6) 2 - 1 4 2 1
Other (5) 5 III (5) 1 - 2 - 2 -
CC7 (9) 7 5 (56%) Ia (4), IV (1) 2 1 - - 1 1
Other (3) 4 Ib (3), V(1) 2 - - 1 1 -
ST-226/ST-314
(2)
2 Ia (1), II (1) 1 - - - 1 -
ST-300/ST-303
(2)
2 ND (2) - - - - 2 -
Singletons (8) Various (6) 8 II (2), III (2), V (2), ND (2) 2 - 1 1 4 -
Total (189) 51 189 71 5 17 59 34 3
%1, percentage of strains of the ST in the CC
ND: Not determinable
100 
200 
300 
400 
500 
600 
 
                
Figure 1 Polymorphism of four VNTRs. The polymorphism of VNTRs (SAG2, SAG3, SAG4 and SAG22) is shown by agarose gel electrophoresis
of PCR products. The first strain on each gel is the reference strain and the PCR products were loaded alongside a 100 bp DNA size ladder (the
sizes in base pairs are shown on the left side of the first panel). The allele number, corresponding to the number of repeats, is indicated under
the band.
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Table 4 MLVA genotypes resolved by the MLVA-6 scheme
MLVA
Genotypes
Allelic
Profile
Total
(189)
Origin of strains (No. of strains) STs
(No. of strains)
Serotypes
Vaginal
carriage
(71)
Gastric
fluid
(5)
Blood
(17)
Cerebral-spinal
fluid
(59)
Bovine
(34)
Ref
(3)
1 3,2,1,8,14,5 5 2 1 - - 1 1 ST-7 Ia (4), IV
2 4,3,2,0,5,5 1 - - - 1 - - ST-23 Ia
3 4,3,1,0,11,5 1 - - - 1 - - ST-23 Ia
4 4,3,1,5,11,5 1 - - - 1 - - ST-23 Ia
5 3,2,3,10,5,5 1 1 - - - - - ST-314 Ia
6 3,3,1,6,16,6 3 2 - 1 - - - ST-10 (2), ST-41 Ia, II, V
7 4,3,1,5,11,2 1 1 - - - - - ST-23 Ia
8 4,3,3,10,14,3 1 1 - - - - - ST-1 V
9 3,3,1,10,9,4 1 - - - - 1 - ST-304 Ib
10 3,3,1,7,14,6 1 - - - - 1 - ST-10 Ib
11 3,3,1,6,12,3 2 1 - 1 - - - ST-10 Ib
12 3,3,1,6,14,3 2 1 - 1 - - - ST-8, ST-12 Ib
13 3,3,1,6,8,6 1 - - 1 - - - ST-12 Ib
14 3,3,1,6,14,6 2 1 - 1 - - - ST-12, ST-200 Ib
15 3,3,1,10,6,3 1 - - - 1 - - ST-6 Ib
16 3,3,3,6,14,3 2 1 - - 1 - - ST-8, ST-196 Ib, IV
17 3,3,1,6,6,6 1 - - - 1 - - ST-10 Ib
18 3,3,1,10,10,4 2 1 - - 1 - - ST-6, ST-195 Ib, III
19 3,3,1,6,10,3 1 1 - - - - - ST-10 Ib
20 3,3,1,6,10,6 1 1 - - - - - ST-12 Ib
21 3,2,1,5,14,6 1 1 - - - - - ST-10 Ib
22 3,3,6,15,4,3 1 - - - - 1 - ST-301 II
23 3,3,6,10,2,4 1 - - - - 1 - ST-313 II
24 3,3,6,15,4,4 1 - - - - 1 - ST-301 II
25 3,2,4,24,5,4 1 - - - - 1 - ST-226 II
26 3,2,1,10,4,5 1 - - - - 1 - ST-63 II
27 3,3,1,6,0,6 2 1 - - - 1 - ST-2 II
28 3,3,6,15,2,6 1 - - - - 1 - ST-64 II
29 3,3,1,6,0,5 1 - 1 - - - - ST-2 II
30 2,3,6,0,3,5 1 - - 1 - - - ST-22 II
31 2,2,5,0,3,5 1 1 - - - - - ST-22 II
32 3,3,1,5,0,2 3 3 - - - - - ST-28 II
33 3,3,3,5,0,2 11 8 - 1 2 - - ST-19 (9), ST-131, ST-
408
II (3), III (7),
V
34 3,3,1,5,6,2 1 1 - - - - - ST-28 II
35 3,3,1,6,6,3 1 1 - - - - - ST-12 II
36 3,2,1,7,16,6 1 1 - - - - - ST-10 II
37 2,3,1,0,19,1 1 - - - - 1 - ST-305 III
38 3,3,1,0,17,1 1 - - - - 1 - ST-23 III
39 3,3,3,5,14,2 1 - - - - 1 - ST-19 III
40 3,3,1,0,7,5 2 - - 1 - 1 - ST-199, ST-307 III
41 3,3,1,0,14,5 1 - - - - 1 - ST-311 III
42 3,3,1,0,26,5 1 - - - - 1 - ST-23 III
43 3,2,1,0,2,6 1 - - - - 1 - ST-309 III
44 3,3,6,0,2,6 1 - - - - 1 - ST-310 III
45 3,3,6,0,5,6 1 - - - - 1 - ST-61 III
46 2,2,2,10,6,3 32 7 1 2 22 - - ST-17 (30), ST-201 III (31), NT
47 2,2,2,10,8,3 13 6 - 1 6 - - ST-17 (12), ST-315 III
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Table 4 MLVA genotypes resolved by the MLVA-6 scheme (Continued)
48 3,3,3,6,0,2 4 2 - 1 - - 1 ST-19 (3), ST-110 III (3), V
49 3,3,1,0,5,4 1 - - 1 - - - ST-198 III
50 3,3,1,0,20,5 1 - - 1 - - - ST-23 III
51 2,2,2,10,3,3 6 2 - - 4 - - ST-17 III
52 2,2,2,5,5,3 1 - - - 1 - - ST-17 III
53 2,2,2,10,5,3 3 1 - - 2 - - ST-17 III
54 2,2,2,9,6,3 1 - - - 1 - - ST-17 III
55 2,2,2,10,7,3 1 - - - 1 - - ST-17 III
56 2,2,2,6,8,3 1 - - - 1 - - ST-17 III
57 3,3,3,5,6,2 7 - - - 7 - - ST-19 III
58 3,3,3,6,6,2 1 - - - 1 - - ST-19 III
59 3,3,3,5,11,2 1 - - - 1 - - ST-19 III
60 3,3,1,0,10,5 1 - - - 1 - - ST-23 III
61 3,3,1,0,18,2 1 - - - - - 1 ST-23 III
62 2,2,2,10,8,2 1 1 - - - - - ST-17 III
63 3,3,3,7,2,2 1 1 - - - - - ST-27 III
64 3,3,3,5,3,2 1 1 - - - - - ST-19 III
65 3,3,2,5,6,2 2 2 - - - - - ST-19 III
66 3,3,1,0,27,2 1 1 - - - - - ST-366 III
67 3,3,3,10,7,3 2 2 - - - - - ST-1 V
68 3,3,3,5,15,3 1 1 - - - - - ST-19 III
69 3,3,1,0,24,3 1 1 - - - - - ST-23 III
70 3,3,3,5,0,4 1 1 - - - - - ST-107 III
71 3,3,3,0,7,4 1 - - - 1 - - ST-196 IV
72 3,3,3,0,10,3 1 1 - - - - - ST-2 IV
73 3,3,3,6,15,3 1 1 - - - - - ST-196 IV
74 2,2,1,8,5,1 1 - - - - 1 - ST-302 NT
75 3,3,6,15,7,2 2 - - - - 2 - ST-61 NT
76 3,3,5,8,2,3 1 - - - - 1 - ST-67 NT
77 3,3,6,0,4,4 1 - - - - 1 - ST-301 NT
78 3,3,5,8,4,4 1 - - - - 1 - ST-67 NT
79 3,3,3,9,4,4 1 - - - - 1 - ST-85 NT
80 3,2,1,8,5,4 1 - - - - 1 - ST-300 NT
81 3,2,1,8,10,4 1 - - - - 1 - ST-303 NT
82 3,3,3,10,0,6 2 - - - - 2 - ST-250 NT
83 3,3,3,0,4,6 1 - - - - 1 - ST-312 NT
84 3,3,3,10,6,6 1 - - - - 1 - ST-250 NT
85 3,3,3,10,0,7 1 - - - - 1 - ST-306 NT
86 3,3,3,6,18,2 1 - 1 - - - - ST-197 NT
87 3,3,3,10,11,3 2 - - 1 1 - - ST-1 NT, V
88 3,3,3,10,28,3 3 2 - 1 - - - ST-1, ST-186 NT, V
89 3,3,3,10,40,3 1 - - 1 - - - ST-2 NT
90 3,3,3,6,5,2 1 1 - - - - - ST-19 NT
91 3,3,2,10,19,3 1 1 - - - - - ST-1 V
92 3,3,2,0,7,6 1 - - - - 1 - ST-26 V
93 3,3,3,0,16,3 1 - 1 - - - - ST-202 V
94 3,2,3,10,7,3 1 1 - - - - - ST-1 V
95 3,3,3,10,26,3 1 1 - - - - - ST-1 V
96 3,3,3,10,30,3 1 1 - - - - - ST-1 V
97 3,3,3,10,35,5 1 1 - - - - - ST-1 V
98 3,3,2,0,24,6 1 1 - - - - - ST-26 V
Each MLVA genotype is expressed as its allelic profile, corresponding to the number of repeats at each VNTR (SAG2, SAG3, SAG4, SAG7, SAG21 and SAG22)
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were confined to four MLVA genotypes (genotypes 46,
47, 51 and 57). An MLVA cluster was defined by a cut-
off value of 50% similarity with the UPGMA algorithm
(Figures 2 and 3). Nine MLVA clusters, each containing
more than four strains, were identified (MLVA clusters
1 to 9) (Figures 2 and 3 and Figure 4A). All clusters
other than cluster 1 were congruent with the two algo-
rithms, UPGMA and MST.
Comparison of MLVA and MLST clustering
MLVA clustering showed a clonal distribution of the
population similar to that obtained by MLST (Figure 4).
All human strains of MLST CC17 clustered together in
MLVA cluster 9 and the bovine strains of MLST CC17
belonged to several MLVA clusters, suggesting greater
heterogeneity of this population (Figure 4). With the
exception of 3 strains, the MLST CC19 strains clustered
into 2 linked MLVA clusters, MLVA cluster 6 and
MLVA cluster 7. The MLST CC23 strains of serotype
III and the MLST CC10 strains clustered into MLVA
cluster 2. The strains from MLST CC23 serotype Ia also
formed a separate group, the MLVA cluster 8.
Discrimination of S. agalactiae strains by MLVA
The diversity index obtained with MLVA was 0.960
(95% CI [0.943 - 0.978]), which is greater than that
obtained with MLST (0.881). For the population studied,
MLVA distinguished 98 genotypes, whereas MLST dis-
tinguished 51 different STs. A much higher level of
diversity was observed with MLVA, particularly within
the major CCs. For example, the 73 CC17 strains were
separated into 12 STs by MLST and 22 MLVA geno-
types; the 63 CC19 strains were separated into 15 STs
by MLST and 35 MLVA genotypes and the 15 CC23
strains were separated into 6 STs by MLST and 15
MLVA genotypes. Nevertheless, two genotypes (46 and
47) accounted for 76% (45/59) of CC17 strains of
human origin. For this particular genogroup, the discri-
minatory power of the MLVA method was greater than
that of MLST, although it remained low.
Discussion
In this study, we applied the multi locus VNTR analysis
(MLVA) typing method to S. agalactiae. VNTR analysis,
a method based on tandem repeat polymorphisms at
multiple loci, has been successfully applied to many
other bacterial species [30,41]. We investigated the rele-
vance of this tool for the genotyping of S. agalactiae, by
testing this method on six VNTR loci in 189 strains pre-
viously characterized by MLST and serotyping. The
MLVA-6 scheme is inexpensive and can be carried out
with the equipment routinely used for PCR amplifica-
tion and agarose gel electrophoresis. For the six VNTR
loci, amplification was achieved with all the strains
tested. For SAG7, a second PCR targeting a larger flank-
ing region was required for 14% of the strains, which
did not have a 16 kb genomic island encompassing the
VNTR. The repeat sizes of the six VNTRs were suffi-
ciently large for evaluation of the number of repeats on
agarose gels. Moreover, the conversion of results into
allelic profiles should make it possible to construct data-
bases for exchange between laboratories. The MLVA-6
scheme includes a set of markers with different diversity
indices, making it suitable for epidemiological studies.
Markers with a moderate diversity and small number of
alleles (presumably reflecting their slow rate of evolu-
tion) define clusters, whereas markers displaying more
rapid evolution reflect variability within clusters. The
MLVA-6 method described here is a rapid, reproducible
and epidemiologically meaningful typing tool.
Three loci studied in the present MLVA scheme are
in common with the MLVA scheme proposed by Radtke
et al. [32]. The 3 additional loci studied here provide
more weight to clusters while maintaining a high discri-
mination power. Moreover, in the MLVA scheme pro-
posed here, only one locus (SAG7) was missing in some
strains (14%), and another primer pair targeting larger
consensual flanking region confirmed the absence of
this locus with a specific amplification. Unlike Radtke et
al., we sought to develop a MLVA scheme in which a
PCR product was amplified in all strains whether the
VNTR was present or absent. In fact, negative amplifica-
tion may result from the lack of a VNTR locus or modi-
fication of the flanking regions, especially as some
VNTRs are close to transposases or insertion sequences
such as SAG4 (alias SATR1) which is close to IS1381.
Thus, the possibility of negative amplification for 3 out
of 5 VNTR loci in the Radtke et al. MLVA analysis
could be a real problem in terms of resolution and
reproducibility of the genotyping method. Nevertheless,
cumulative works allow to define the best set of VNTR
loci, as has already been done for other bacterial species
such as Mycobacterium tuberculosis [22,42-46] and Sta-
phylococcus aureus [30,47-49]. Finally, the study of 34
isolates of bovine origin provided information about
their distribution, especially those belonging to MLST
CC17.
Population analysis by MLVA revealed a clonal distri-
bution of the strains similar to that obtained by MLST.
The greater discriminatory index of MLVA (0.96) made
it possible to distinguish between strains within the clo-
nal complexes defined by MLST. Thus, MLVA divided
CC23 into two groups: one associated with serotype III
and the other associated with serotype Ia. Moreover,
MLVA also separated CC17 into two groups: one corre-
sponding to strains of human origin and the other, con-
taining several related STs (ST-61, ST-64, ST-301 etc.),
corresponding to strains of animal origin only. A
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previous study analyzing 75 strains of S. agalactiae of
human and animal origin by whole-genome DNA-array
hybridization also separated ST-23 strains into two clus-
ters, one associated with serotype III and the other with
serotype Ia [50]. Each of these two clusters was asso-
ciated with a particular pattern of surface protein
expression. This previous study also separated the
bovine and human CC17 strains [50]. These results are
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Figure 2 MLVA clustering of the 189 strains of S. agalactiae by the UPGMA method, run in BioNumerics. The names of strains (Strain Id),
MLST clonal complex (CC), MLST sequence type (ST), MLST profile, serotype and the origin of strains are shown on the right. A cutoff value of
50% similarity was applied to define MLVA clusters (named MLVA cluster 1 to MLVA cluster 9). The colors used are based on MLVA clusters.
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consistent with an ancient divergence of these clusters,
whereas other observations based on MLST analysis
suggest that ST-17 strains may have arisen from a
bovine ancestor [6]. The lack of a strict correlation
between the results of MLST and MLVA may be
accounted for by differences in the markers used for
MLST (targeting housekeeping genes) and MLVA (tar-
geting a set of diverse regions that may or may not be
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Figure 3 MLVA clustering of the 189 strains of S. agalactiae by the UPGMA method, run in BioNumerics. The names of strains (Strain Id),
MLST clonal complex (CC), MLST sequence type (ST), MLST profile, serotype and the origin of strains are shown on the right. A cutoff value of
50% similarity was applied to define MLVA clusters (named MLVA cluster 1 to MLVA cluster 9). The colors used are based on MLVA clusters.
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conserved). Unlike MLST, MLVA targets several types of
markers: genes involved in metabolism, genes associated
with virulence and a genomic island. Indeed, SAG2 is
located upstream from the gene encoding the ribosomal
protein S10 which is involved in transcription and trans-
lation, and SAG3 is located within dnaJ, which encodes a
member of the Hsp70 family, a co-chaperone protein
(Hsp40). The SAG21 locus encodes a surface protein
involved in virulence, FbsA. The SAG7 locus is located
on a genomic island and belongs to a gene encoding a
hypothetical protein whose function has not yet been
identified, like most of the genes of genomic islands [51].
Clustering based on MLVA data was almost identical
with the UPGMA and MST algorithms except for cluster
1. The differences in mathematical calculation between
the two methods may account for the observed differ-
ences in strain clustering. This phenomenom has been
previously observed in MLVA studies [52].
Some VNTRs for the alpha C protein have already
been described in S. agalactiae [41,53,54]. One of these
VNTRs is involved in regulating gene expression: a pen-
tanucleotide repeat located upstream from the promoter
regulates expression in vitro by phase variation. Another
is an intragenic VNTR that modifies the size of the
alpha C protein, thereby altering its antigenicity and
strain virulence [53]. These two VNTR loci were not
included in the MLVA method proposed here, in one
case because the small size of the repeat unit (5 bp)
complicates the mode of PCR fragment size assessment
[19]. The amplicons of the second VNTR locus not
included were more than 2000 bp in size, again making
it difficult to evaluate repeat number. Tandem repeats
were also found in the gene encoding another surface
protein, FbsA, which interacts with epithelial cells and is
involved in invasion of the central nervous system of
colonized neonates. Its ability to bind to fibrinogen
depends on the number of repeats of a unit of 16 amino
acids present at its N-terminus [55]. A particular num-
ber of repeats is associated with the greater potential of
the ST-17 strains implicated in neonatal meningitis to
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Figure 4 Minimum spanning tree (MST) representation of the MLVA clustering. The colors used in figure 4A are based on MLVA clusters.
The colors used in figure 4B are based on MLST clonal complexes. White circles correspond to genotypes not clustered by MLVA or MLST. The
MLVA data for 189 strains, including 3 reference strains, were analyzed in BioNumerics. Each circle represents an MLVA genotype and its size is
proportional to the number of strains. A logarithmic scale was used when drawing branches. The thicker branches link the MLVA genotypes
differing by only one allele, the thinner branches link MLVA genotypes differing by more than one allele.
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adhere to fibrinogen [56]. This major marker was
included in our MLVA method and corresponds to
SAG21.
Conclusions
The MLVA method proposed here is a simple genotyp-
ing method producing results that can be exchanged
between laboratories. MLVA generated major clusters
that corresponded well to the main clonal complexes
obtained by MLST. However its discriminatory power
provided was greater that that of MLST. MLVA could
also therefore be used as an epidemiological tool, given
its high discriminatory power, making it possible to dis-
tinguish between strains of homogenous lineages. The
specificities of the VNTRs for each phylogenetic lineage
raise questions about the role of VNTRs in the adapta-
tion of S. agalactiae to its environment and in virulence.
Further studies are required to clarify these issues.
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